Genrelix Tk Hek Hkk

Deadline: 01 Jan 2028

Germany

Ref. No.: 21605755

EMD:Ref Document

Bid Value: Ref Document

697 Days Left

Estradiol Spt Tk Hek Hkk

Deadline: 01 Jan 2028

Germany

Ref. No.: 21605730

EMD:Ref Document

Bid Value: Ref Document

697 Days Left

Cetrorelix Tk Hek Hkk

Deadline: 01 Jan 2028

Germany

Ref. No.: 21605705

EMD:Ref Document

Bid Value: Ref Document

697 Days Left

Open House Biologics Discount Agreements 2025 31 Denosumab

Deadline: 30 Nov 2027

Germany

Ref. No.: 21602424

EMD:Ref Document

Bid Value: Ref Document

665 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Golimumab Atc Code According To Who L04Ab06

Deadline: 31 Dec 2026

Germany

Ref. No.: 21601989

EMD:Ref Document

Bid Value: Ref Document

331 Days Left

Drug Discount Contracts With Membership Option

Deadline: 01 Nov 2027

Germany

Ref. No.: 21595464

EMD:Ref Document

Bid Value: Ref Document

636 Days Left

Open House Biologics Discount Agreements 2025 25 Aflibercept Atc S01La05 Potency 40 Mg Ml

Deadline: 30 Nov 2026

Germany

Ref. No.: 21591258

EMD:Ref Document

Bid Value: Ref Document

300 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Tocilizumab Atc Code According To Who L04Ac07

Deadline: 31 Dec 2026

Germany

Ref. No.: 21582181

EMD:Ref Document

Bid Value: Ref Document

331 Days Left

Open House Originals Discount Agreements 2025 33 Propranolol Dosage Form Oral Solution

Deadline: 31 Dec 2027

Germany

Ref. No.: 21571781

EMD:Ref Document

Bid Value: Ref Document

696 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21564607

EMD:Ref Document

Bid Value: Ref Document

331 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Sgb V With The Possibility Of Joining At Any Time So Called Approval Model 2024 09

Deadline: 05 Sep 2026

Germany

Ref. No.: 21563849

EMD:Ref Document

Bid Value: Ref Document

214 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21556595

EMD:Ref Document

Bid Value: Ref Document

331 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 21551066

EMD:Ref Document

Bid Value: Ref Document

331 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Pamidronic Acid Atc Code According To Who M05Ba03

Deadline: 31 Jan 2028

Germany

Ref. No.: 21540832

EMD:Ref Document

Bid Value: Ref Document

727 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Teriparatide Atc Code According To Who H05Aa02

Deadline: 31 Jan 2028

Germany

Ref. No.: 21532995

EMD:Ref Document

Bid Value: Ref Document

727 Days Left

Discover Tenders by Pharmaceutical Glassware Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Pharmaceutical Glassware Sector

Filter Your Search

FREE Trial plan for all new users!